Showing results (141-150 of 303) with videos related to
Sort By:
Pageof 31
Cancer Research|March 1, 1985
Selective cytotoxicity of the SM1 monoclonal antibody towards small cell carcinoma of the lungS D Bernal, M Mabry, R A Stahel, et al.The EMBO Journal|January 16, 1995
Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABLT Matsuguchi, R C Inhorn, N Carlesso, et al.American Journal of Hematology|June 1, 1993
Hematologic remission and cytogenetic improvement after treatment of stable-phase chronic myelogenous leukemia with continuous infusion of low-dose cytarabineM J Robertson, R Tantravahi, J D Griffin, et al.Antioxidants (Basel, Switzerland)|September 9, 2020
Anti-inflammatory and Anti-oxidant Activity of Hidrox® in Rotenone-Induced Parkinson's Disease in MiceRosalba Siracusa, Maria Scuto, Roberta Fusco, et al.Journal of Neuroscience Research|November 19, 2016
Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer diseaseManuela Pennisi, Rosalia Crupi, Rosanna Di Paola, et al.Blood|October 1, 1992
Interferon-gamma increases the expression of the gene encoding the beta subunit of the granulocyte-macrophage colony-stimulating factor receptorM Hallek, E M Lepisto, K E Slattery, et al.British Journal of Cancer|May 25, 2006
AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABLE Weisberg, P Manley, J Mestan, et al.Leukemia|March 1, 1997
The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteinsN Uemura, R Salgia, J L Li, et al.Blood|May 1, 1986
Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemiaJ D Griffin, D Young, F Herrmann, et al.Pageof 31